Philip Morris International acquires Fertin Pharma for $820m
Leveraging Fertin Pharma’s expertise, PMI plans to offer a wide range of smoke-free products such as nicotine pouches.
Denmark
Latest in
Denmark
Novo Nordisk to acquire Prothena’s ATTR amyloidosis unit for up to $1.2bn
Novo Nordisk plans to first clinically develop Prothena’s ATTR amyloidosis candidate, PRX004, for ATTR cardiomyopathy treatment.
Philip Morris agrees to acquire Fertin Pharma for $820m
Fertin Pharma, to be acquired by Philip Morris, produces gums, tablets and other solid oral systems for pharmaceutical and nutraceutical…
Novo Nordisk reports increased Q1 2021 profit
Novo Nordisk has reported a net profit of kr12.6bn ($2.03bn) for the first quarter (Q1) of 2021, which represents an…
Novo Nordisk’s Rybelsus launch defies 2020 full-year sales expectations, despite the economic impacts of the Covid-19 pandemic
Novo Nordisk’s launch of Rybelsus (semaglutide) in Q4 2019 has defied full-year sales expectations in 2020, a year defined by…
By
LEO Pharma divests four medicines to Cheplapharm for $357m
Danish medical dermatology company LEO Pharma has divested a portfolio of four non-core medicines to German pharmaceutical firm Cheplapharm for…
Bavarian Nordic licences Covid-19 vaccine from AdaptVac
Bavarian Nordic has signed a final agreement with AdaptVac to licence a capsid virus like particle (cVLP) based SARS-CoV-2 subunit…
Eir Ventures launches to unlock the potential of the Nordics
Supported by three prestigious investment companies and the EU's EIF, Eir Ventures is a Nordic-based venture company with €76m to…
By